Techno Medica Co., Ltd.

Symbol: 6678.T

JPX

1731

JPY

Market price today

  • 11.1298

    P/E Ratio

  • 0.5840

    PEG Ratio

  • 12.10B

    MRK Cap

  • 0.03%

    DIV Yield

Techno Medica Co., Ltd. (6678-T) Financial Statements

On the chart you can see the default numbers in dynamics for Techno Medica Co., Ltd. (6678.T). Companys revenue shows the average of 8503.725 M which is 0.021 % gowth. The average gross profit for the whole period is 4106.725 M which is 0.025 %. The average gross profit ratio is 0.483 %. The net income growth for the company last year performance is -0.102 % which equals 0.085 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Techno Medica Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.054. In the realm of current assets, 6678.T clocks in at 17307.03 in the reporting currency. A significant portion of these assets, precisely 11750.289, is held in cash and short-term investments. This segment shows a change of 0.020% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 210, if any, in the reporting currency. This indicates a difference of 43.836% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 0 in the reporting currency. This figure signifies a year_over_year change of 0.000%. Shareholder value, as depicted by the total shareholder equity, is valued at 16386.854 in the reporting currency. The year over year change in this aspect is 0.047%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 3574, with an inventory valuation of 1865.52, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 22.98.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

41232.611750.311523.510138.6
9762.1
9518.6
9327.3
8238.6
7959.1
7539.6
6119.1
5516.1
4663
4153.6
3696.2
3469.1
3953.5

balance-sheet.row.short-term-investments

-697.13-202.5-138.5-163.5
-111.5
-141.5
0
0
0
-35.7
-65.9
-68.4
-68.4
0
0
0
0

balance-sheet.row.net-receivables

10496.55357436523605
3320
3217
3156
2658.1
3182.5
4901
4359
4130.3
4328.2
3677.4
3731.2
3882.7
3034.1

balance-sheet.row.inventory

8453.841865.51229.31646
1359.4
1595.8
1195.5
1483.6
2006
1596.5
1701.9
1623.3
1459.9
1247.4
1037.1
876.5
474

balance-sheet.row.other-current-assets

2085.55438.6564.5461.5
496.8
386.9
294.4
229.8
194.1
1.1
-71.4
-61.8
-35.2
-67.4
0.4
0.8
26.3

balance-sheet.row.total-current-assets

61582.431730716472.815470.6
14512.2
14386.8
13973.2
12610
13341.7
14038.3
12108.5
11207.9
10415.9
9011
8464.9
8229.1
7487.9

balance-sheet.row.property-plant-equipment-net

6008.431527.61492.51564.5
1605.4
1267.8
1256.5
1264.6
1292
1356.2
1420.2
1319.5
1266
1300.4
1334.2
1205.8
945.8

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

230.45233323.9
29.1
35.4
19.1
23
22.3
31
35.5
5
6.5
8.3
9
5.3
4.5

balance-sheet.row.goodwill-and-intangible-assets

230.45233323.9
29.1
35.4
19.1
23
22.3
31
35.5
5
6.5
8.3
9
5.3
4.5

balance-sheet.row.long-term-investments

727.17210146171
119
149
0
7.5
7.5
43.3
73.4
75.9
75.9
7.5
7.5
7.5
7.5

balance-sheet.row.tax-assets

1504375.3363.4324.8
304.7
316.6
97.9
113.6
43.4
131.2
148
139
154
145.9
138.3
124.4
112.4

balance-sheet.row.other-non-current-assets

310.570.20.6-0.3
-0.4
-0.4
146.4
97.1
94.2
93.6
60.2
61.9
86.3
143.3
118.7
108.4
99.9

balance-sheet.row.total-non-current-assets

8780.622136.12035.52083.9
2057.7
1768.4
1519.9
1505.8
1459.3
1655.2
1737.4
1601.4
1588.7
1605.4
1607.7
1451.4
1170.2

balance-sheet.row.other-assets

0.01000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

70363.0619443.218508.217554.4
16569.9
16155.2
15493.2
14115.7
14801.1
15693.5
13846
12809.3
12004.6
10616.4
10072.6
9680.6
8658.1

balance-sheet.row.account-payables

4258.11499.61282.51134.8
1081.5
1111.8
1233.3
1002
1810.9
2202.8
1669
1709.7
1724
1398.5
1700.5
1768
1268.7

balance-sheet.row.short-term-debt

-448.06-98.8-114.5-134.3
-147.8
-129.6
0
0
0
0
0
0
100
100
144.8
157.6
176.7

balance-sheet.row.tax-payables

561.45248.7518.6460.2
224.8
293.8
416.5
316.2
452.2
628.2
538.3
508
572.3
396.9
251.5
288.7
315.4

balance-sheet.row.long-term-debt-total

0000
0
0
0
0
0
0
0
0
0
0
0
44.8
102.4

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

4667.121310.91347.71249.5
1145.5
1031.8
948
597.5
687.7
845.6
743.4
725.3
9.4
9.9
10.3
8.7
7.9

balance-sheet.row.total-non-current-liabilities

1002.6245.9228210
193.6
269.8
294.2
347.4
221.3
300.2
286
316
350.9
352.7
346.6
356
382.8

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

9927.823056.32858.22594.3
2420.6
2413.4
2475.4
1946.9
2719.9
3348.6
2698.5
2751
2933.1
2397.4
2565.2
2720.7
2299.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

4279.21069.81069.81069.8
1069.8
1069.8
0
1069.8
1069.8
1069.8
1069.8
1069.8
1069.8
1069.8
1069.8
1069.8
1069.8

balance-sheet.row.retained-earnings

50333.916090.954614616.1
3892.6
3795.1
3582.8
10449.1
10361.2
10307.4
9109.9
8020.6
7033.8
6181.3
5469.7
4922.1
4321.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

8818.488818.58818.58818.5
8818.5
8318.5
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-2996.35407.6300.9455.7
368.4
558.5
9434.9
649.9
650.2
967.7
967.8
967.9
967.9
967.9
967.9
967.9
967.9

balance-sheet.row.total-stockholders-equity

60435.2416386.915650.114960.1
14149.3
13741.8
13017.7
12168.8
12081.2
12344.9
11147.5
10058.3
9071.5
8219
7507.4
6959.8
6358.9

balance-sheet.row.total-liabilities-and-stockholders-equity

70363.0619443.218508.217554.4
16569.9
16155.2
15493.2
14115.7
14801.1
15693.5
13846
12809.3
12004.6
10616.4
10072.6
9680.6
8658.1

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

60435.2416386.915650.114960.1
14149.3
13741.8
13017.7
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

70363.06---
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

30.047.57.57.5
7.5
7.5
7.5
7.5
7.5
7.5
7.5
7.5
7.5
7.5
7.5
7.5
7.5

balance-sheet.row.total-debt

0000
0
0
0
0
0
0
0
0
100
100
144.8
202.4
279.1

balance-sheet.row.net-debt

-41232.6-11750.3-11523.5-10138.6
-9762.1
-9518.6
-9327.3
-8238.6
-7959.1
-7539.6
-6119.1
-5516.1
-4563
-4053.6
-3551.4
-3266.7
-3674.4

Cash Flow Statement

The financial landscape of Techno Medica Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 1.505. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 217.01 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -155370000.000 in the reporting currency. This is a shift of -1.062 from the previous year. In the same period, the company recorded 108.06, -16.63, and 0, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -505.09 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 0, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

1233.221665.81851.11649.3
1339
1549.6
1670.8
607.4
1803
2323.3
2159.5
1944.8
1831.3
1453.6
1274.6
1387.9
1410.5

cash-flows.row.depreciation-and-amortization

112.16108.1121120.8
94
71
71.4
72.5
74.7
90.3
54.7
41.5
38.6
43.8
38.3
24.8
26.7

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-244.8721.1-684
323.4
-394.4
165
14.6
114.6
198.7
-348.6
67
-594.8
-453.3
-72.8
-746.1
-361.9

cash-flows.row.account-receivables

077-46-283
-102
1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-636.2416.7-286.6
236.5
-400.3
288.1
522.4
448.4
105.4
-78.6
-163.4
-212.5
-210.3
-160.6
-402.5
-63.5

cash-flows.row.account-payables

0217147.753.3
-30.3
-121.5
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

097.4202.7-167.6
219.3
126.4
-123.1
-507.8
-333.8
93.4
-270.1
230.4
-382.3
-243
87.7
-343.6
-298.4

cash-flows.row.other-non-cash-items

-1121.06-641.8-630.2-260.8
-487.2
-521.9
-390.1
1
-916.9
-883
-814
-770.7
-542.1
-299.2
-556.6
-542.2
-531.7

cash-flows.row.net-cash-provided-by-operating-activities

224.32000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-138.7-80.2-33.9
-425.5
-98.6
-59.4
-45.9
-1.8
-21.7
-194.6
-87.7
-1.4
-17.6
-161.3
-285.5
-2.9

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

000-120.2
-130.2
-120.2
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

002568.60
0
0
0
0
40.4
2.7
20
25.2
0
0
0
0
0

cash-flows.row.other-investing-activites

0-16.60.70.4
2.5
-28.4
-109.3
-120.1
-121
-121.1
-138.5
-130.2
59.5
-124.8
-124.7
-125.4
-130.4

cash-flows.row.net-cash-used-for-investing-activites

0-155.42489.1-153.7
-553.1
-247.2
-168.6
-166
-82.5
-140.1
-313.1
-192.7
58.1
-142.3
-286
-410.9
-133.3

cash-flows.row.debt-repayment

0000
0
0
0
0
0
0
0
-100
0
-44.8
-57.6
-76.7
-284.5

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

00-164.40
-200
-0.1
0
-0.3
-317.6
-0.1
-0.1
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-505.1-434.2-415.3
-402.9
-385.8
-369.9
-370.1
-376.3
-288.9
-265.8
-257
-222.3
-222.2
-235.9
-244.5
-215.2

cash-flows.row.other-financing-activites

00-1640
0
0
0
0
0
0
0
0
0
0
0
0
100

cash-flows.row.net-cash-used-provided-by-financing-activities

0-505.1-598.6-415.3
-602.9
-385.9
-369.9
-370.4
-693.9
-289
-265.9
-357
-222.3
-267
-293.5
-321.2
-399.7

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-3172.97226.83953.5256.4
113.2
71.2
978.6
159.1
299.1
1300.2
472.6
732.7
568.7
335.4
104
-607.6
10.7

cash-flows.row.cash-at-end-of-period

41232.611750.311523.57570
7313.6
7200.4
7129.2
6150.7
5991.6
5692.4
4392.2
3919.6
3186.9
2618.2
2282.8
2178.8
2786.4

cash-flows.row.cash-at-beginning-of-period

44405.5711523.575707313.6
7200.4
7129.2
6150.7
5991.6
5692.4
4392.2
3919.6
3186.9
2618.2
2282.8
2178.8
2786.4
2775.7

cash-flows.row.operating-cash-flow

224.32887.22063825.4
1269.3
704.3
1517.1
695.5
1075.5
1729.3
1051.7
1282.5
732.9
744.8
683.6
124.4
543.6

cash-flows.row.capital-expenditure

0-138.7-80.2-33.9
-425.5
-98.6
-59.4
-45.9
-1.8
-21.7
-194.6
-87.7
-1.4
-17.6
-161.3
-285.5
-2.9

cash-flows.row.free-cash-flow

224.32748.51982.8791.5
843.8
605.6
1457.7
649.6
1073.7
1707.6
857
1194.8
731.5
727.2
522.3
-161.1
540.7

Income Statement Row

Techno Medica Co., Ltd.'s revenue saw a change of 0.073% compared with the previous period. The gross profit of 6678.T is reported to be 4630.29. The company's operating expenses are 2980.84, showing a change of 0.860% from the last year. The expenses for depreciation and amortization are 108.06, which is a -0.107% change from the last accounting period. Operating expenses are reported to be 2980.84, which shows a 0.860% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.158% year-over-year growth. The operating income is 1649.45, which shows a -0.114% change when compared to the previous year. The change in the net income is -0.102%. The net income for the last year was 1150.73.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

9730.639367.69699.19040.1
9810.5
9332.4
8654.2
8457.2
9032.4
9519.6
9000.1
8151.2
7980.9
7559.5
7055.2
6730.9
6668.6

income-statement-row.row.cost-of-revenue

4873.064737.34881.84585.7
5312.1
4977.8
4651.5
4337.5
5022.7
4990.7
4467.3
3953.6
3912.3
3766.1
3876.1
3464.2
3415.3

income-statement-row.row.gross-profit

4857.564630.34817.34454.4
4498.5
4354.6
4002.7
4119.7
4009.7
4528.9
4532.8
4197.6
4068.6
3793.3
3179.1
3266.8
3253.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

370.43---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

85---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

164---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

19.317.15.515.4
10.7
16.3
-2.3
-21.2
3.1
2.5
3
3.7
3.1
2.9
2
1.3
1.6

income-statement-row.row.operating-expenses

3104.022980.82955.42846.6
3240.7
2836.8
2511.1
2701
2368.8
2208.7
2376.8
2257.2
2239.8
2342
1908.2
1883.9
1879.1

income-statement-row.row.cost-and-expenses

7977.087718.17837.27432.3
8552.8
7814.6
7162.6
7038.6
7391.5
7199.4
6844
6210.8
6152.1
6108.1
5784.3
5348
5294.4

income-statement-row.row.interest-income

0.230.21.20.3
0.3
0.3
0.3
0.5
1.6
1.3
1.2
1.1
1.4
3
4.6
7.5
6.1

income-statement-row.row.interest-expense

001.20
0
0.1
0.1
0.1
0.1
0.1
0.7
0.4
2.1
1.4
2.9
3.7
6.1

income-statement-row.row.selling-and-marketing-expenses

164---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

22.27161341
80
31
179.2
-811.3
162.1
3
3.5
4.4
2.5
2.2
3.8
4.9
36.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

19.317.15.515.4
10.7
16.3
-2.3
-21.2
3.1
2.5
3
3.7
3.1
2.9
2
1.3
1.6

income-statement-row.row.total-operating-expenses

22.27161341
80
31
179.2
-811.3
162.1
3
3.5
4.4
2.5
2.2
3.8
4.9
36.4

income-statement-row.row.interest-expense

001.20
0
0.1
0.1
0.1
0.1
0.1
0.7
0.4
2.1
1.4
2.9
3.7
6.1

income-statement-row.row.depreciation-and-amortization

56.76108.1121120.8
94
71
70.5
72.5
74.7
90.3
54.7
41.5
38.6
43.8
38.3
24.8
26.7

income-statement-row.row.ebitda-caps

1753.66---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

1753.551649.51861.91607.8
1257.8
1517.8
1491.6
1418.7
1641
2320.3
2156
1940.4
1828.8
1451.3
1270.8
1382.9
1374.2

income-statement-row.row.income-before-tax

1776.441665.81851.11649.3
1339
1549.6
1670.8
607.4
1803
2323.3
2159.5
1944.8
1831.3
1453.6
1274.6
1387.9
1410.5

income-statement-row.row.income-tax-expense

543.19515569.7496.1
338.6
451.5
362.3
149.2
606
836.7
804.5
701
756.8
520
490.6
541.7
537.3

income-statement-row.row.net-income

1233.251150.71281.41153.3
1000.5
1098.1
1308.5
458.1
1197
1486.5
1355.1
1243.7
1074.4
933.5
784.1
846.2
873.2

Frequently Asked Question

What is Techno Medica Co., Ltd. (6678.T) total assets?

Techno Medica Co., Ltd. (6678.T) total assets is 19443171000.000.

What is enterprise annual revenue?

The annual revenue is 4653677000.000.

What is firm profit margin?

Firm profit margin is 0.499.

What is company free cash flow?

The free cash flow is 28.404.

What is enterprise net profit margin?

The net profit margin is 0.127.

What is firm total revenue?

The total revenue is 0.180.

What is Techno Medica Co., Ltd. (6678.T) net profit (net income)?

The net profit (net income) is 1150733000.000.

What is firm total debt?

The total debt is 0.000.

What is operating expences number?

The operating expences are 2980841000.000.

What is company cash figure?

Enretprise cash is 8058100000.000.